/
QNRX
$6.50+$0.16 (+2.72%)live
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Market cap
$11.8M
2M shares
52-week range
$3.25 – $41.80
8% from low
Sector
PHARMACEUTICAL PREPARATIONS
Exchange
NASDAQ
ADRC
Change$-61103.95
Quoin Pharmaceuticals, Ltd. American Depositary Shares
Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.
www.quoinpharma.com- Employees
- 6
- IPO / List date
- Oct 28, 2021
- HQ
- KFAR SABA
Held by traders on TradeandTell
No one on the platform currently holds QNRX.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in QNRX as of their last filing.
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|---|
| 2025-04-09 | 1-for-35reverse |
| 2023-07-18 | 1-for-12reverse |
| 2022-08-01 | 1-for-12.5reverse |
| 2021-09-24 | 1-for-4reverse |
| 2019-10-23 | 1-for-5reverse |
Recent trades on TradeandTell
No one on the platform has traded QNRX yet.
